Publications by authors named "Ezgi Turkoglu"

Claim this Profile
T
The Effect of the Clinical-Pathological CPS+EG Staging System on Survival Outcomes in Patients with HER2-Positive Breast Cancer Receiving Neoadjuvant Treatment: A Retrospective Study.
Seval Orman, Miray Aydoğan, Oğuzcan Kınıkoğlu, Sedat Yıldırım, Nisanur Sarıyar Busery

Medicina (Kaunas)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the efficacy of mFOLFOX-6 and mDCF regimens in the treatment of metastatic gastric cancer: a multicenter retrospective study.
Ogur Karhan, Serdar İleri, Zuhat Urakçı, Yasin Sezgin, Ümit Yıldırım

Ther Adv Med Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Family and Personal Medical History on Treatment Outcomes of Tyrosine Kinase Inhibitors (TKIs) in Non-Small Cell Lung Cancer (NSCLC).
Heves Surmeli, Ezgi Turkoglu, Deniz Isik, Oguzcan Kinikoglu, Yunus Emre Altintas

Healthcare (Basel)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of paclitaxel and docetaxel in dual HER2 blockade: efficacy and safety in neoadjuvant treatment of HER2-positive breast cancer.
Ezgi Turkoglu, Goncagul Akdag Topal, Sedat Yildirim, Oguzcan Kinikoglu, Nisanur Sariyar Busery

Breast Cancer Res Treat· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Association of Khorana Risk Score with Venous Thromboembolism and Overall Survival in Patients with Metastatic Gastric Cancer.
Ezgi Turkoglu, Goncagul Akdag Topal, Sedat Yıldırım, Oguzcan Kınıkoglu, Nisanur Sarıyar Busery, Furkan Turkoglu

Medicina (Kaunas)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-Line Chemotherapy Versus CDK4/6 Inhibitors in HR-Positive, HER2-Negative Breast Cancer with Liver Metastases: A Multicenter Real-World Data.
Mehmet Cem Fidan, Ahmet Emin Öztürk, Okan Aydın, Goncagül Akdağ, Ezgi Türkoğlu

J Clin Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of repolishing on the color stability of a supra-nano spherical filled composite resin: An in vitro study.
Merve Haberal, Ezgi Türkoğlu, Yusuf Bayraktar

J Dent Res Dent Clin Dent Prospects· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Male breast cancer in a single-center experience: Diagnosis, clinicopathological features, and treatment strategies.
Deniz Isik, Oguzcan Kinikoglu, Ezgi Turkoglu, Heves Surmeli, Neslihan Buyukmurat

North Clin Istanb· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the Effectiveness of Nivolumab in Metastatic Lung Cancer Among Patients Aged 65 and Older.
Deniz Isik, Özkan Alan, Goncagül Akdağ, Sedat Yildirim, Oğuzcan Kınıkoğlu, Ezgi Turkoglu

J Clin Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant Chemotherapy and Pathologic Complete Response in HR+/HER2- Breast Cancer: Impact of Tumor Ki67 and ER Status.
Goncagul Akdag, Sedat Yildirim, Akif Dogan, Zeynep Yuksel Yasar, Hamit Bal, Ezgi Turkoglu

Chemotherapy· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does Adjuvant Chemotherapy Benefit Patients with T4 N0 Colon Cancer?
Goncagul Akdag, Deniz Isik, Akif Dogan, Sedat Yildirim, Oguzcan Kinikoglu, Ezgi Turkoglu

Medicina (Kaunas)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Effectiveness of Targeted Therapies Following Nivolumab Therapy in Patients with Metastatic Renal Cell Carcinoma: A Real-World Study.
Deniz Işık, Oğuzcan Kınıkoğlu, Goncagül Akdağ, Yunus Emre Altıntaş, Ezgi Türkoğlu

Medicina (Kaunas)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the Clinical Impact of RANK Pathway Inhibition in Advanced Breast Cancer: Insights From a Retrospective Study on CDK4/6 Inhibitors and Antiresorptive Therapy.
Goncagul Akdag, Akif Dogan, Sedat Yildirim, Oguzcan Kinikoglu, Muhammed Edib Mokresh, Ezgi Turkoglu

Cureus· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis